A Study to Evaluate the Bioequivalence of Ruxolitinib Extended Release (XR) Tablets With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants
Clinical trial NCT06555081 · COMPLETED
Trial details
- NCT number
- NCT06555081
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2024-10-25
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.